Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nuclear Factor-Kappa B and Alzheimer Disease, Unifying Genetic and Environmental Risk Factors from Cell to Humans
Simon Vann Jones, Ilias Kounatidis
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

Cellular Specificity of NF-κB Function in the Nervous System
Erica C. Dresselhaus, Mollie K. Meffert
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 263
Curcumin’s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases
Bahare Salehi, Daniela Călina, Anca Oana Docea, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 2, pp. 430-430
Open Access | Times Cited: 162
Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer’s Disease
Sachchida Nand, Charan Singh, Arti Singh, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 7, pp. 3075-3088
Closed Access | Times Cited: 142
The effects of microglia-associated neuroinflammation on Alzheimer’s disease
Cuicui Wang, Shuai Zong, Xiaolin Cui, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 140
Apoptotic Pathways and Alzheimer’s Disease: Probing Therapeutic Potential
Vivek Sharma, Thakur Gurjeet Singh, Shareen Singh, et al.
Neurochemical Research (2021) Vol. 46, Iss. 12, pp. 3103-3122
Closed Access | Times Cited: 139
Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age
Ashley Payne, Samuel N. Nahashon, Equar Taka, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 371-371
Open Access | Times Cited: 109
Inflammation context in Alzheimer’s disease, a relationship intricate to define
Catalina Novoa, Paulina Salazar, Pedro Cisternas, et al.
Biological Research (2022) Vol. 55, Iss. 1
Open Access | Times Cited: 95
Anti-Inflammatory and Antioxidative Phytogenic Substances against Secret Killers in Poultry: Current Status and Prospects
Shereen Basiouni, Guillermo Téllez‐Isaías, Juan D. Latorre, et al.
Veterinary Sciences (2023) Vol. 10, Iss. 1, pp. 55-55
Open Access | Times Cited: 49
Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease
Niraj Kumar Jha, Saurabh Kumar Jha, Rohan Kar, et al.
Journal of Neurochemistry (2019) Vol. 150, Iss. 2, pp. 113-137
Open Access | Times Cited: 135
Role of NF-κB in Ageing and Age-Related Diseases: Lessons from Genetically Modified Mouse Models
Verónica A. García-García, Josefa P. Alameda, Angustias Page, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 1906-1906
Open Access | Times Cited: 85
Inflammation and Alzheimer’s Disease: Mechanisms and Therapeutic Implications by Natural Products
Mashoque Ahmad Rather, Andleeb Khan, Saeed Alshahrani, et al.
Mediators of Inflammation (2021) Vol. 2021, pp. 1-21
Open Access | Times Cited: 65
Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery
Duygu Ege
Materials (2021) Vol. 14, Iss. 12, pp. 3332-3332
Open Access | Times Cited: 61
Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
Ankit Verma, Anna Shteinfer‐Kuzmine, Nikita Kamenetsky, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 58
The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders
Richard C. J. Bradlow, Michael Berk, Peter W. Kalivas, et al.
CNS Drugs (2022) Vol. 36, Iss. 5, pp. 451-482
Open Access | Times Cited: 57
Mechanistic insight into female predominance in Alzheimer’s disease based on aberrant protein S-nitrosylation of C3
Hongmei Yang, Chang-ki Oh, Haitham Amal, et al.
Science Advances (2022) Vol. 8, Iss. 50
Open Access | Times Cited: 42
The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice
Timur Zanikov, Marta Gerasymchuk, Esmaeel Ghasemi Gojani, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2624-2624
Open Access | Times Cited: 29
Genetic overlap between Alzheimer’s disease and immune-mediated diseases: an atlas of shared genetic determinants and biological convergence
Nitesh Enduru, Brisa S. Fernandes, Shahram Bahrami, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 8, pp. 2447-2458
Open Access | Times Cited: 12
Brain Injury–Mediated Neuroinflammatory Response and Alzheimer’s Disease
Duraisamy Kempuraj, Mohammad Ejaz Ahmed, Govindhasamy Pushpavathi Selvakumar, et al.
The Neuroscientist (2019) Vol. 26, Iss. 2, pp. 134-155
Open Access | Times Cited: 75
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease
Arianna Bellucci, Luigi Bubacco, Francesca Longhena, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 69
Identification of Conserved Proteomic Networks in Neurodegenerative Dementia
Vivek Swarup, Timothy S. Chang, Duc M. Duong, et al.
Cell Reports (2020) Vol. 31, Iss. 12, pp. 107807-107807
Open Access | Times Cited: 66
Psychedelics as a Treatment for Alzheimer’s Disease Dementia
Simon Vann Jones, Allison O’Kelly
Frontiers in Synaptic Neuroscience (2020) Vol. 12
Open Access | Times Cited: 51
Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer’s disease
Haoshen Shi, Yosef Koronyo, Dieu‐Trang Fuchs, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 51
Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease
Md. Sahab Uddin, Md. Tanvir Kabir, Maroua Jalouli, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 1, pp. 126-146
Open Access | Times Cited: 50
Redox Homeostasis in Poultry: Regulatory Roles of NF-κB
Peter F. Surai, Ivan I. Kochish, Michael T. Kidd
Antioxidants (2021) Vol. 10, Iss. 2, pp. 186-186
Open Access | Times Cited: 46
The neurobiology and therapeutic potential of multi-targeting β-secretase, glycogen synthase kinase 3β and acetylcholinesterase in Alzheimer’s disease
Mariana G. Fronza, Diego Alves, Domenico Praticò, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102033-102033
Closed Access | Times Cited: 22
Page 1 - Next Page

Scroll to top